The role of endogenous opioid peptides in the antinociceptive effect of 15-deoxyΔ12,14-prostaglandin J2 in the temporomandibular joint

被引：11
作者：
Macedo, C. G. [1 ]
Napimoga, M. H. [2 ]
Rocha-Neto, L. M. [1 ]
Abdalla, H. B. [1 ]
Clemente-Napimoga, J. T. [1 ]
机构：
[1] Univ Campinas UNICAMP, Piracicaba Dent Sch, Dept Physiol Sci, Lab Orofacial Pain, Av Limeira 901, BR-13414903 Piracicaba, SP, Brazil
[2] Rio Leopoldo Mand Inst & Res Ctr, Lab Immunol & Mol Biol, Rua Jose Rocha Junqueira 13, BR-13045755 Campinas, SP, Brazil
来源：
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 2016年 / 110卷
基金：
巴西圣保罗研究基金会;
关键词：
ACTIVATED-RECEPTOR-GAMMA; TRANSIENT FOCAL ISCHEMIA; SPINAL-CORD-INJURY; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); INFLAMMATORY PAIN; NEUROPATHIC PAIN; PERIPHERAL ANTINOCICEPTION; NEUTROPHIL MIGRATION; SIGNALING PATHWAY; RATS;
D O I：
10.1016/j.plefa.2016.05.009
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
We have previously demonstrated that peripheral administration of 15d-PGJ(2) in the Temporomandibular joint (TMJ) of rats can prevent nociceptor sensitization, mediated by peroxisome proliferator activated receptor-gamma (PPAR-gamma), and kappa- and delta- opioid receptors. However, the mechanism that underlies the signaling of PPAR-gamma (upon activation by 15d-PGJ(2)) to induce antinociception, and how the opioid receptors are activated via 15d-PGJ(2) are not fully understood. This study demonstrates that peripheral antinociceptive effect of 15d-PGJ(2) is mediated by PPAR-gamma expressed in the inflammatory cells of TMJ tissues. Once activated by 15d-PGJ(2), PPAR-gamma induces the release of beta-endorphin and dynorphin, which activates kappa- and delta-opioid receptors in primary sensory neurons to induce the antinociceptive effect. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码：27 / 34
页数：8
相关论文
共 50 条
  • [21] 15-Deoxy-Δ12,14-prostaglandin J2 as a potential regulator of bone metabolism via PPARγ-dependent and independent pathways: a review
    Xiong, Zhencheng
    Luo, Pan
    Zhou, Jun
    Tan, Mingsheng
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 1879 - 1888
  • [22] Alteration of biochemical and pathological properties of TDP-43 protein by a lipid mediator, 15-deoxy-Δ12,14-prostaglandin J2
    Zhang, Hai-Xin
    Tanji, Kunikazu
    Yoshida, Hidemi
    Hayakari, Makoto
    Shibata, Takahiro
    Mori, Fumiaki
    Uchida, Koji
    Wakabayashi, Koichi
    EXPERIMENTAL NEUROLOGY, 2010, 222 (02) : 296 - 303
  • [23] 15-Deoxy-Δ12,14-prostaglandin J2, an electrophilic lipid mediator of anti-inflammatory and pro-resolving signaling
    Surh, Young-Joon
    Na, Hye-Kyung
    Park, Jong-Min
    Lee, Ha-Na
    Kim, Wonki
    Yoon, In-Soo
    Kim, Dae-Duk
    BIOCHEMICAL PHARMACOLOGY, 2011, 82 (10) : 1335 - 1351
  • [24] Synthesis and Evaluation of the Novel Prostamide, 15-Deoxy, Δ12,14-Prostamide J2, as a Selective Antitumor Therapeutic
    Ladin, Daniel A.
    Soliman, Eman
    Escobedo, Rene
    Fitzgerald, Timothy L.
    Yang, Li V.
    Burns, Colin
    Van Dross, Rukiyah
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (05) : 838 - 849
  • [25] 15-Deoxy-Δ12,14-prostaglandin J2 prevents inflammatory response and endothelial cell damage in rats with acute obstructive cholangitis
    Watanabe, Katsutaka
    Yokoyama, Yukihiro
    Kokuryo, Toshio
    Kawai, Kiyotaka
    Kitagawa, Tomomi
    Seki, Takashi
    Nakagawa, Akifumi
    Nagino, Masato
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2010, 298 (03): : G410 - G418
  • [26] A plausible involvement of plasmalemmal voltage-dependent anion channel 1 in the neurotoxicity of 15-deoxy-Δ12,14-prostaglandin J2
    Koma, Hiromi
    Yamamoto, Yasuhiro
    Okamura, Noboru
    Yagami, Tatsurou
    BRAIN AND BEHAVIOR, 2020, 10 (12):
  • [27] 15-Deoxy-Delta-12,14-Prostaglandin J2 Inhibits Lung Inflammation and Remodeling in Distinct Murine Models of Asthma
    Coutinho, Diego S.
    Anjos-Valotta, Edna A.
    do Nascimento, Caio V. M. F.
    Pires, Ana Lucia A.
    Napimoga, Marcelo H.
    Carvalho, Vinicius F.
    Torres, Rafael C.
    Silva, Patricia M. R. e
    Martins, Marco A.
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [28] 15-Deoxy-Δ12,14-Prostaglandin J2 Biphasically Regulates the Proliferation of Mouse Hippocampal Neural Progenitor Cells by Modulating the Redox State
    Katura, Takashi
    Moriya, Takahiro
    Nakahata, Norimichi
    MOLECULAR PHARMACOLOGY, 2010, 77 (04) : 601 - 611
  • [29] HtrA3 is regulated by 15-deoxy-Δ12,14-prostaglandin J2 independently of PPARγ in clear cell renal cell carcinomas
    Theoleyre, Sandrine
    Mottier, Stephanie
    Masson, Damien
    Denis, Marc G.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 394 (03) : 453 - 458
  • [30] 15-Deoxy-Δ12,14-prostaglandin J2 prevents oxidative injury by upregulating the expression of aldose reductase in vascular smooth muscle cells
    Kang, E. S.
    Hwang, J. S.
    Ham, S. A.
    Park, M. H.
    Kim, G. H.
    Paek, K. S.
    Yoo, T.
    Lee, W. J.
    Kang, K. R.
    Lee, J. H.
    Choi, Y. J.
    Seo, H. G.
    FREE RADICAL RESEARCH, 2014, 48 (02) : 218 - 229
12345